Tocolytic therapy in obstetrics.
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D000242:Cyclic AMP / Q000502:physiology; D000431:Ethanol / Q000494:pharmacology; D005260:Female; D006470:Hemorrhage / Q000188:drug therapy; D006801:Humans; D008991:Monitoring, Physiologic; D009130:Muscle, Smooth / Q000187:drug effects; D007744:Obstetric Labor Complications / Q000188:drug therapy; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010208:Papaverine / Q000494:pharmacology; D010276:Parasympatholytics / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D010923:Placenta Previa / Q000150:complications; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011453:Prostaglandins / Q000502:physiology; D011941:Receptors, Adrenergic; D014590:Uterine Contraction / Q000187:drug effects*; D014599:Uterus / Q000601:surgery; D014700:Verapamil / Q000494:pharmacology
D000318:Adrenergic beta-Agonists; D010276:Parasympatholytics; D011453:Prostaglandins; D011941:Receptors, Adrenergic; D000431:Ethanol; D014700:Verapamil; D010208:Papaverine; D000242:Cyclic AMP